COVID-19 & Psychiatry: A Retrospective Chart Review

Active, not recruiting

• Conditions: COVID-19
• Interventions: Other: No intervention

• Registration Number: NCT05244096
• Lead Sponsor: Northwestern University

Brief Summary

A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.

Detailed Description

The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.

Study Timeline

• Study Start: 2022-01-12
• Study First Submitted: 2022-02-15
• Study First Submitted QC: 2022-02-15
• Study First Posted: 2022-02-17
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-03
• Last Update Posted: 2024-04-05
• Primary Completion: 2025-03-30
• Study Completion: 2025-03-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 65000

Inclusion Criteria

• Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
COVID+	No intervention	COVID + positive individuals from March 15 2020 to Nov 30, 2021

Primary Outcome Measures

Name	Time	Method
Hazard Ratio	March 15 2020 to Nov 30 2021	HR of using psych drugs or having psych diagnosis

Trial Locations

Locations (1)

Northwester Clinical Research Program; 🇺🇸 Chicago, Illinois, United States